Claire Graham and Stella O’Malley, both of Genspect, featured in Medscape

Medscape interviewed both Claire Graham and Stella O’Malley of Genspect for its story on the Tavistock’s appeal to the Keira Bella ruling, “Treat youth with gender dysphoria as individuals.”

Some noteworthy excerpts:

“We need to learn from the mistakes made with people like Keira Bell. Clinicians need to realize that fast-tracking counseling doesn’t work, especially when [children are]…young and especially when they’re traumatized,” O’Malley said.

“Had they received a more conventional therapy, they might have thought about their decision from different perspectives and in the process acquired more self-awareness, which would have been more beneficial.” 

“The ‘affirmative’ approach to gender therapy is too narrow, we need to look at the whole individual. Therapy in other areas would never disregard other, nongender issues such as attention deficit hyperactivity disorder or anxiety [which often co-exist with gender dysphoria] — issues bleed into each other,” O’Malley pointed out. “We need a more exploratory approach.”  

Claire Graham noted that “Parents are rightly concerned about their children’s ability to consent to treatments that may lead to infertility and issues surrounding sexual function.” 

Claire Graham
Claire Graham, intersex/DSD advocate and Genspect team member

“Many parents worry that their child is not being considered in the whole [and] that their child’s ability to consent to medical interventions for gender dysphoria is impacted by comorbidities, such as a diagnosis of autism, or a history of mental health issues. These children are particularly vulnerable.”

“At Genspect, we hope that the decision from the…court is upheld,” Graham concluded.

The appeal was heard on June 23 and 24, with a decision expected sometime this summer.

Copy link
Powered by Social Snap